Spots Global Cancer Trial Database for Tumor Registry of Advanced Renal Cell Carcinoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Tumor Registry of Advanced Renal Cell Carcinoma
Official Title: Clinical Registry Describing Treatment Reality and Therapy Modality of Patients With Metastatic or Locally Advanced Renal Cell Carcinoma Requiring Therapy
Study ID: NCT00610012
Conditions
Interventions
Study Description
Brief Summary: The purpose of this registry is to record information of therapy reality of metastatic or locally advanced Renal Cell Carcinoma by office-based medical oncologists in Germany.
Detailed Description: The RCC Registry is a prospective, longitudinal, nation wide cohort study that collects data on the treatment reality of patients with mRCC. At inclusion, data in patient characteristics, comorbidities, tumor characteristics, and previous treatments are collected. During the course of observation data on all systemic treatments, radiotherapies, surgeries, and outcome are documented. Patients are followed until death or for a maximum of 3 years.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
iOMEDICO, Freiburg, , Germany
Contact Details
Name: Goebell Peter, MD
Affiliation: Waldkrankenhaus St. Marien, Erlangen, Germany
Role: STUDY_CHAIR
Name: Lothar Müller, MD
Affiliation: Onkologie Leer - Emden - Papenburg, Germany
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
